Behcet Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Behcet disease (BEH-chets), sometimes called Behcet syndrome, Morbus Behçet, or Silk Road disease, is a rare immune-mediated systemic vasculitis. The more common symptoms include sores in the mouth and on the genitals (sex organs). More serious symptoms can include inflammation (swelling, heat, redness, and pain) in the eyes and other parts of the body. The goal of treatment is to reduce pain and prevent serious problems.
The Behcet Disease pipeline drugs market research report provides comprehensive information on the therapeutics under development for Behcet Disease, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Behcet Disease and features dormant and discontinued projects.
Behcet Disease Pipeline Drugs Market Segmentation by Targets
Some of the targets of the Behcet Disease pipeline drugs market are Phosphodiesterase 4, C-X-C Chemokine Receptor Type 2 , Interleukin 2 Receptor , and Tumor Necrosis Factor.
Behcet Disease Pipeline Drugs Market Analysis, by Targets
For more Behcet Disease pipeline drugs market target insights, download a free report sample
Behcet Disease Pipeline Drugs Market Segmentation by Mechanism of Actions
Some of the mechanisms of action of the Behcet Disease pipeline drugs market are Phosphodiesterase 4 Inhibitor, C-X-C Chemokine Receptor Type 2 Antagonist, Interleukin 2 Receptor Agonist, and Tumor Necrosis Factor Inhibitor.
Behcet Disease Pipeline Drugs Market Analysis, by Mechanism of Actions
For more mechanism of action insights into the Behcet Disease pipeline drugs market, download a free report sample
Behcet Disease Pipeline Drugs Market Segmentation by Routes of Administration
The key routes of administration in the Behcet Disease pipeline drugs market are oral and subcutaneous.
Behcet Disease Pipeline Drugs Market Analysis, by Routes of Administration
For more routes of administration insights into the Behcet Disease pipeline drugs market, download a free report sample
Behcet Disease Pipeline Drugs Market Segmentation by Molecule Types
The molecule types in the Behcet Disease pipeline drugs market are Small Molecule, Monoclonal Antibody, and Recombinant Protein.
Behcet Disease Pipeline Drugs Market Analysis, by Molecule Types
For more molecule type insights into the Behcet Disease pipeline drugs market, download a free report sample
Competitive Landscape
Some of the key companies in the Behcet Disease pipeline drugs market are Amgen Inc, Aristea Therapeutics Inc, Iltoo Pharma, Kangpu Biopharmaceuticals Ltd, and Pharmapraxis.
Behcet Disease Pipeline Drugs Market Analysis, by Leading Companies
To know more about the Behcet Disease pipeline drugs market companies, download a free report sample
Behcet Disease Pipeline Drugs Market Report Overview
Key Targets | Phosphodiesterase 4, C-X-C Chemokine Receptor Type 2 , Interleukin 2 Receptor , and Tumor Necrosis Factor |
Key Mechanism of Actions | Phosphodiesterase 4 Inhibitor, C-X-C Chemokine Receptor Type 2 Antagonist, Interleukin 2 Receptor Agonist, and Tumor Necrosis Factor Inhibitor |
Key Routes of Administration | Oral and Subcutaneous |
Key Molecule Types | Small Molecule, Monoclonal Antibody, and Recombinant Protein |
Key Companies | Amgen Inc, Aristea Therapeutics Inc, Iltoo Pharma, Kangpu Biopharmaceuticals Ltd, and Pharmapraxis |
Scope
This report provides:
- A snapshot of the global therapeutic landscape of Behcet Disease.
- Reviews of pipeline therapeutics for Behcet Disease by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Pipeline products based on several stages of development ranging from pre-registration to discovery and undisclosed stages.
- Descriptive drug profiles for the pipeline products which comprise product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- Reviews key companies involved in Behcet Disease therapeutics and enlists all their major and minor projects.
- Evaluation of Behcet Disease therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA), and molecule type.
- All the dormant and discontinued pipeline projects.
- Reviews of the latest news related to pipeline therapeutics for Behcet Disease.
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with a potentially strong product portfolio and create effective counterstrategies to gain a competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Behcet Disease.
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and their most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Behcet Disease pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from the pipeline.
Table of Contents
Table
Figures
Frequently asked questions
-
What are the key targets of the Behcet Disease pipeline drugs market?
Some of the key targets of the Behcet Disease pipeline drugs market are Phosphodiesterase 4, C-X-C Chemokine Receptor Type 2 , Interleukin 2 Receptor , and Tumor Necrosis Factor.
-
What are the key mechanisms of action in the Behcet Disease pipeline drugs market?
Some of the key mechanisms of action in the Behcet Disease pipeline drugs market are Phosphodiesterase 4 Inhibitor, C-X-C Chemokine Receptor Type 2 Antagonist, Interleukin 2 Receptor Agonist, and Tumor Necrosis Factor Inhibitor.
-
What are the key routes of administration in the Behcet Disease pipeline drugs market?
The key routes of administration in the Behcet Disease pipeline drugs market are oral and subcutaneous.
-
What are the key molecule types in the Behcet Disease pipeline drugs market?
The molecule types in the Behcet Disease pipeline drugs market are Small Molecule, Monoclonal Antibody, and Recombinant Protein.
-
Which are the key companies in the Behcet Disease pipeline drugs market?
Some of the key companies in the Behcet Disease pipeline drugs market are Amgen Inc, Aristea Therapeutics Inc, Iltoo Pharma, Kangpu Biopharmaceuticals Ltd, and Pharmapraxis.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.